AVE 33.3% 0.2¢ avecho biotechnology limited

buy side building strongly, page-85

  1. 5,796 Posts.
    lightbulb Created with Sketch. 736
    JF - welcome back, although we may differ slightly on opinions I have missed your regular thoughts.
    I agree wholeheartedly that TPM needs to be continually pushed, as does POH.
    As a clapper, I feel that they have been doing a reasonable job of late.
    The exposure we really need now is global via Asia which you would then expect to filter back locally.
    In regards to POH, Esra has been racking up the frequent flyer points at the moment travelling as far as Europe and back through Asia. They are pushing POH and TPM big time now with some early results seen in the share price.
    In regards to the commercial promotion of our products and TPM, a great deal will come down to how well Watson's embrace Bio-Elixia. A successful launch and promotion will give us a lot of ammunition locally. It will give the crew a chance to spread the word maybe through ACA etc and every other avenue about the international expansion.
    We are growing quickly and it's a fine balance on where resources should be placed. There is a hell of a lot happening behind the scenes and 24 hours in day is insufficient for POH at the moment.
    It is too crucial a time to lose focus.
    We complained when the SP was hovering at 13c not long ago.
    We also said that we are ultimately judged by the share price. Now b/w 16.5-17.5c we have to give credit that things are working.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $17 5.798K

Buyers (Bids)

No. Vol. Price($)
55 95690716 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 59980558 19
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.